A multiplex chemiluminescent immunoassay for serological profiling of COVID-19-positive symptomatic and asymptomatic patients

The COVID-19 pandemic affects more than 81 million people worldwide with over 1.7 million deaths. As the population returns to work, it is critical to develop tests that reliably detect SARS-CoV-2-specific antibodies. Here we present results from a multiplex serology test for assessing the antibody...

Descripción completa

Detalles Bibliográficos
Autores principales: Grossberg, Allison N., Koza, Lilia A., Ledreux, Aurélie, Prusmack, Chad, Krishnamurthy, Hari Krishnan, Jayaraman, Vasanth, Granholm, Ann-Charlotte, Linseman, Daniel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854643/
https://www.ncbi.nlm.nih.gov/pubmed/33531472
http://dx.doi.org/10.1038/s41467-021-21040-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854643/
https://www.ncbi.nlm.nih.gov/pubmed/33531472
http://dx.doi.org/10.1038/s41467-021-21040-7

Ejemplares similares